T regulatory (Treg) cells are critical for preventing autoimmunity and suppressing immune responses during cancer and chronic infection. However, the role of Treg cells in the generation of vaccine-induced immune memory remains ill-defined. Using the mouse model of lymphocytic choriomeningitis virus (LCMV) infection, we demonstrate that transient absence of Treg cells during effector to memory CD8 T-cell transition results in a permanent impairment in the maintenance, function and recall capacity of CD8 T cells. Memory CD8 T cells in mice that were transiently depleted of Treg cells exhibited defective up-regulation of memory markers with a significant decrease in polyfunctionality. However, Treg-depleted mice showed no significant change in CD4 T-cell responses, and antibody levels relative to control. Altogether, this study evaluates the role of Treg cells in the formation of immune memory and demonstrates an important role for Treg cells in promoting memory CD8 T-cell differentiation and vaccine-induced immune protection against intracellular pathogens.
Introduction
T regulatory (Treg) cells expressing the forkhead transcription factor Foxp3 are necessary to prevent autoimmunity and regulate immune responses to commensals, pathogens, allergens and tumours. [1] [2] [3] Consistent with their suppressive role, the genetic absence of Treg cells results in catastrophic autoimmunity within 3-4 weeks of birth. 1 Moreover, transient depletion of Treg cells during chronic viral infection and cancers results in functional rescue of exhausted CD8 T cells by a mechanism dependent on effector CD4 T-cell activation and B7 costimulation. [4] [5] [6] Overall, these data demonstrate a role for Treg cells in regulating immune responses to persistent antigens, but little is known about how Treg cells modulate immune responses to acutely controlled antigens.
Recently, Treg cells have been proposed to play a role in promoting memory CD8 T-cell responses following acutely controlled viral infection via a mechanism involving the resolution of inflammation by interleukin-10 (IL-10) 7 and cytotoxic T-lymphocyte antigen 4 (CTLA-4). 8 Memory CD8 T-cell differentiation is a stepwise process, including a rapid initial phase of expansion that lasts for approximately a week, followed by a phase of contraction. [9] [10] [11] [12] [13] [14] [15] Previous reports demonstrate that the experimental depletion of Treg cells at the time of priming (before the initial expansion) results in impaired expansion of primary CD8 T-cell responses and reduced memory formation. [16] [17] [18] However, we have shown that experimental depletion of Treg cells after the antigen has been cleared, referred to as 'immune memory timepoints' (~day 100) does not seem to affect the levels of memory CD8 T-cell responses, suggesting time-dependent effects of Treg cells in modulating the function and maintenance of memory CD8 T cells.
Importantly, the role of Treg cells in modulating memory differentiation during the contraction phase of the Tcell response following vaccination remains ill-defined. Moreover, it is unknown whether Treg cells influence various other arms of the immune system at this time of the immune response, namely helper CD4 T-cell responses and antibody responses.
We evaluated the role of Treg cells during the contraction phase of the T-cell response. We found that memory CD8 T cells, but not CD4 T cells or antibody responses, were severely impaired following Treg depletion at the time of T-cell contraction. Taken together, these data improve our understanding of how Treg cells modulate
adaptive immune responses, and demonstrate the context-dependent roles of Treg cells in modulating CD8 T-cell responses following natural infection or vaccination.
Materials and methods

Animals, immunizations and treatments
Six-to eight-week-old, female FoxP3-DTR-GFP (in the C57BL/6 background) mice were purchased from Jackson Laboratories (Bar Harbor, ME). For acutely controlled viral challenges, lymphocytic choriomeningitis virus (LCMV) Armstrong was injected intraperitoneally at 2 9 10 5 plaqueforming units per mouse. For modelling a vaccination regimen, mice were immunized intramuscularly with 10 5 focus-forming units of replication incompetent LCMV Cl-l3 vectors (rCl-13) expressing simian immunodeficiency virus (SIV) strain SIVmac239 Env and Gag, as shown previously. 19 For viral challenges, chronic LCMV Cl-13 was injected intravenously via the lateral tail vein at 2 9 10 6 plaque-forming units per mouse. Diphtheria toxin (DT) treatments were performed intraperitoneally at 0Á5 lg per mouse in 500 ll PBS. 5 This dose of DT is able to deplete > 99% of FoxP3 + Treg cells, consistent with previous reports. 1, 5 All experiments were performed with the approval of the Institutional Animal Care and Use Committee.
Viral vector purification
The rLCMV (rCl-13) vectors expressing SIV antigens were generated and titrated as described previously. 20, 21 These vaccine vectors contain the coding sequence (cDNA) of single SIV vaccine antigens generated by Genscript (Piscataway, NJ) and inserted into a plasmid encoding the GP-deleted S gene segment of LCMV clone 13. Trans-complementing BHK-21 cells genetically expressing the LCMV GP were transfected with plasmids of the vector rescue system and vectors were harvested from the supernatant.
Viral titration
Titration of LCMV in mouse challenge studies was performed on VERO E6 cell (ATCC, Manassas, VA) monolayers by standard plaque assay as previously shown. 22 In brief, three 10-fold serial dilutions from serum samples were distributed on top of the VERO E6 cell monolayers in six-well plates (> 80% confluent). Plates were incubated for a total of 60 min manually rocking every 10 min. After this, a 1 : 1 solution of 1% agarose in 2X199 media (Gibco, Life Technologies, Waltham, MA) was carefully overlaid over the monolayers, and 4 days after, a 1 : 1 solution of 1% agarose in 2X199 media with 1 : 50 neutral red was pipetted on top of each well. Plaques were counted at day 5 based on neutral red exclusion using a transluminator.
Antibodies and flow cytometry
For the tetramer binding assays, cells were stained with anti-CD8a (53-6.7 on Peridinin chlorophyll proteinCy5.5), anti-CD44 (IM7 on Pacific Blue), anti-CD62L (MEL-14 on phycoerythrin-Cy7), anti-CD127 (A7R34 on FITC), anti-PD-1 (RMP1-30 on phycoerythrin). For Treg stains, we used anti-CD4 (RM4-5 on Peridinin chlorophyll protein-Cy5.5) and anti-FoxP3 (FJK-16s on allophycocyanin). All surface anti-mouse antibodies were purchased from BD Pharmingen (San Diego, CA), except for CD44 (BioLegend, San Diego, CA). Biotinylated MHC I monomers were obtained from the NIH Tetramer facility. Intracellular cytokine staining for anti-interferon-c (XMG1.2 on allphycocyanin), anti-tumour necrosis factor-a (MP6-XT22 on phycoerythrin-Cy7, and anti-IL-2 (JES6-5H4 on phycoerythrin) was performed with the Cytofix/Cytoperm kit (BD Biosciences). Samples were acquired using an LSR II flow cytometer (BD Biosciences, San Jose, CA) and analysed using FLOWJO (Treestar, Ashland, OR).
Statistical analysis
Statistical analyses were performed using two-tailed nonparametric Mann-Whitney U-tests in GRAPHPAD PRISM software (GraphPad, San Diego, CA.
Results
Dynamics of Treg cell reconstitution following transient Treg cell depletion
We assessed the effect of a transient Treg cell depletion using FoxP3-DTR-GFP mice, which allow for the easy visualization and ablation of Treg cells following DT administration. We first infected mice with acutely controlled LCMV Armstrong, and we treated mice intraperitoneally with 0Á5 lg of DT or PBS control on days 12, 13, 16 and 19 post-infection (Fig. 1a) . Treatment of mice with DT resulted in complete depletion of Treg cells within a day (Fig. 1b) , and Treg cells rebounded to their original levels within a week after the last DT treatment (Fig. 1c) . This constituted a model for assessing the effect of transient Treg depletion on adaptive immune responses, and this model did not result in lethal autoimmunity, as lethal autoimmunity can only be induced after 3-4 weeks of continuous Treg depletion. longitudinal analysis of Treg responses revealed a transient decrease in Treg cells within the first week, which corresponded to the peak of the T-cell response, but Treg cells rapidly returned to normal levels after the second week, which corresponded to the time of effector to memory transition (Fig. 2a) . Strikingly, Treg depletion in FoxP3-DTR-GFP mice from day 12 through to day 19 of an acutely controlled LCMV Armstrong infection resulted in impaired maintenance of LCMV-specific CD8 T-cell responses ( Fig. 2b-d ). However, we did not observe significant differences between PBS and DT treatment in wildtype mice (Fig. 2e) .
In addition, transient Treg depletion also resulted in impaired cytokine expression by memory CD8 T-cell responses specific for dominant and subdominant LCMV epitopes (Fig. 3a) . There was a slight pattern of reduced CD4 T-cell responses (GP61-80 specific) in Treg-depleted mice, but this was not statistically significant (P = 0Á5). Although the mean per-cell expression of interferon-c by memory CD8 T cells was similar between both groups, per-cell expression of tumour necrosis factor a and IL-2 was significantly reduced in mice that were Treg depleted relative to control (Fig. 3b,c) .
Moreover, Treg depletion resulted in defective up-regulation of memory markers. Mice that were Treg depleted exhibit delayed CD127 and CD62L up-regulation on memory CD8 T cells ( Fig. 4a-c ). In addition, Treg-depleted mice also showed a defect in the expression of the transcription factor T-bet (Fig. 4d) , and increased PD-1 levels on virus-specific CD8 T cells relative to control mice (Fig. 4e) . We did not notice any statistically significant differences in virus-specific IgG antibody levels by ELISA (Fig. 5 ).
Transient Treg depletion during effector to memory transition results in impaired anamnestic expansion of vaccine-induced memory CD8 T-ell responses
Until now, all of our experiments have used replicating live virus (LCMV Armstrong). We then evaluated the effect of transient Treg depletion in a vaccination setting with replication-incompetent LCMV vectors expressing SIVmac239 Env and Gag (rCl-13-SIV). We immunized FoxP3-DTR-GFP mice intramuscularly with 10 5 focus-forming units of these vectors and depleted Treg cells on days 12, 13, 16 and 19 post-vaccination (Fig. 6a) . In this setting, Treg depletion only resulted in a minor, not statistically significant, decrease in SIV transgene-specific (SIV and Gag) and LCMV vector backbone-specific (NP396) CD8 T-cell responses by day 30 (Fig. 6b,c) . However, following vaccine boosting, mice that were transiently Treg-depleted at day 12 of prime exhibited a profound impairment in recall expansion relative to control (Fig. 6b,c) . We did not notice statistically significant differences in anamnestic CD4 T-cell responses (P = 0Á8) (Fig. 6d) .
Transient Treg depletion during effector to memory transition results in impaired vaccine-induced immune protection
We then decided to evaluate immune protection following vaccination and transient Treg depletion. We 6 plaqueforming units of chronic LCMV Cl-13 (Fig. 7a) , which is known to induce a chronic infection in unvaccinated mice. 10 Vaccination with replication-incompetent rCl-13 vectors followed by replicating LCMV Cl-13 challenge is a model that we have developed to assess vaccine-induced protection in mice. 19 We measured viral loads after challenge by plaque assays, and this showed a 12-fold higher viraemia at day 6 in mice that were transiently Tregdepleted after rCl-13 vaccination (P = 0Á008), but at day 15 post-challenge, all vaccinated mice had cleared the infection (Fig. 7b) . In addition, there were greater frequencies of LCMV-specific CD8 T cells in control mice at day 15 post-challenge (Fig. 7c) , and these expressed lower PD-1 levels relative to mice that were Treg-depleted (Fig. 7d) .
Interestingly, our data also showed that Treg responses in unvaccinated mice (which became chronically infected upon Cl-13 challenge) undergo a transient decline during the first week (5Á2-fold decrease, P = 0Á0001). This is followed by a drastic rebound in Treg responses after the second week of challenge (12Á2-fold increase, P < 0Á0001). However, vaccinated mice, all of which controlled the chronic viral infection, did not show this exaggerated Treg expansion after the second week, suggesting that vaccine-induced immune protection alters Treg dynamics following chronic viral challenge (Fig. 7e,f) . Overall, CD8 T-cell responses can be divided into various phases, including: (i) primary effector expansion, (ii) contraction, (iii) quiescent memory and (iv) anamnestic expansion. Importantly, memory CD8 T-cell differentiation can be influenced by inflammatory stimuli. Consistent with this, the strength of the priming stimulus influences the levels of memory CD8 T cells, and virus-specific CD8 T cells primed at the beginning of an infection undergo more drastic terminal effector differentiation, whereas those primed at the end of a viral infection (during the resolution phase) undergo improved memory differentiation. 24, 25 Treg cells have been shown to play a role in reducing inflammation during the resolution of an acute viral infection, 7 but little is known about how they modulate the various arms of the adaptive immune response. Although previous reports have demonstrated a role for Treg cells in promoting the maturation of memory CD8 T cells following acute LCMV infection 7 or ovalbumin immunization, 17 we make several novel observations. First, we show a specific discrete time in which Treg cells are needed to promote effector to memory CD8 Tcell differentiation following an acutely controlled viral infection (LCMV Armstrong). We showed that a very transient Treg depletion after the resolution of infection results in long-lasting impairment in the maintenance of memory CD8 T cells, noticeable even > 400 days after challenge. We performed experimental Treg depletion at day 12 post-infection, which corresponds to a time when the LCMV Armstrong infection has been cleared from the mouse. 10 During this time, effector CD8 T-cell responses undergo contraction and differentiation into memory CD8 T cells expressing the homeostatic marker CD127, which is the IL-7Ra chain and identifies long-lived memory CD8 T cells, 26 as well as CD62L, also referred to as L-selectin, which is expressed on central memory CD8 T cells.
27
CD62L marks a subset of CD8 T cells, referred to as central memory CD8 T cells, that exhibit great anamnestic expansion following secondary antigen exposure. 27 Importantly, transient Treg depletion resulted in impaired upregulation of both markers (CD127 and CD62L) and resulted in defects in cytokine expression and polyfunctionality. Moreover, our transient Treg depletion also resulted in reduced expression of the T-box transcription factor T-bet on memory CD8 T cells, which is marker involved in memory CD8 T-cell differentiation. 9 Consistent with the role of T-bet in repressing PD-1 expression, 28 , we noticed an inverse association between T-bet and PD-1 levels, with Treg-depleted mice showing higher PD-1 levels on memory CD8 T cells relative to control mice.
Following CD8 T-cell priming, T-bet together with Eomes help to induce the expression of granzyme B, interferon and perforin, CXCR3 and CXCR4, [29] [30] [31] [32] and the absence of these transcription factors is associated with abnormal and pathological memory CD8 T-cell responses. 33 Second, we generalize our observations to a primeboost vaccination setting using replication-defective SIV vaccines that we have pre-clinically tested in non-human primates as candidate HIV vaccines. 19 We show in a prime-boost immunization regimen that Treg cells are also needed to generate effective vaccine-induced CD8 Tcell responses that can undergo robust recall expansion following vaccine boosting.
Third, we use a stringent chronic virus challenge system to assess the contribution of vaccine-induced immune responses to immune protection. As the acute control of LCMV Cl-13 is strictly dependent on CD8 T cells, 34, 35 we conclude that most (perhaps all) of the observed impairment in immune protection was due to defective induction of memory CD8 T cells following transient vaccination and Treg depletion. However, all vaccinated mice cleared the chronic viral challenge by day 15, suggesting that memory CD8 T cells generated in Treg-depleted mice were nonetheless able to control the infection if given sufficient time to expand and control the viral infection. Importantly, vaccination not only resulted in protection against chronic LCMV Cl-13, but it also restricted Treg expansion after chronic viral challenge, consistent with a previous report that shows a direct correlation between viral loads and Treg levels. 36 Importantly, Treg expansion following chronic infection has been suggested to be a main reason for immune exhaustion. 5, 6, [37] [38] [39] It is important to mention that chronic LCMV Cl-13 infection does not generate LCMV-specific Treg responses, and most expanded Treg cells in this infection model seem to be specific for endogenous retroviruses. 40 Fourth, we demonstrate that although transient Treg depletion induces impairment of memory CD8 T-cell responses, it does not seem to affect substantially the memory CD4 T-cell response and the antibody response. This is an important and undescribed observation, and suggest that memory CD4 T-cell responses and humoral responses are able to bypass, at least partially, the inflammatory signals present during the effector phase of the infection. Future studies will address whether Treg depletion can influence other parameters of the humoral response, including antibody-mediated neutralization and antibody-mediated effector functions. Taken together, our data highlight the effects of transient Treg depletion on adaptive immune responses following viral infection or vaccination. These data are important for improving our understanding of immune memory and for rational vaccine design.
